Traitement pharmacologique de l'état de mal réfractaire [Drug treatment of refractory status epilepticus]

Détails

ID Serval
serval:BIB_4CDC0F9A7B51
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
Traitement pharmacologique de l'état de mal réfractaire [Drug treatment of refractory status epilepticus]
Périodique
Revue Neurologique
Auteur⸱e⸱s
Rossetti A.O., Santoli F.
ISSN
0035-3787
Statut éditorial
Publié
Date de publication
2009
Peer-reviewed
Oui
Volume
165
Numéro
4
Pages
373-379
Langue
français
Résumé
Status epilepticus (SE) refractory to benzodiazepines and other antiepileptic agents is managed with intravenous anesthetic compounds, such as thiopental, propofol or midazolam. These drugs display quite different pharmacodynamic and pharmacokinetic properties, but have not been prospectively compared to date. Their use is clearly advocated for the treatment of generalized convulsive SE, whereas partial-complex, or absence SE are generally managed less aggressively, in consideration of their better prognosis. The most important aspect seems to be related to the correct use of these anesthetics in the right context, rather than the choice of one specific compound. An electroencephalographic burst-suppression should be targeted for about 24hour, before progressive weaning of the dosage under EEG monitoring. If this approach proves unsuccessful, the use of other drugs, including inhalational anesthetics, has been described.
Pubmed
Web of science
Création de la notice
13/05/2009 17:10
Dernière modification de la notice
20/08/2019 15:01
Données d'usage